When tragedy struck and Sarah Thompson’s baby, Liam, was stillborn at 34 weeks, she found herself determined to uncover the reasons behind her loss. Despite an uncomplicated pregnancy, the sudden passing of her otherwise healthy baby left her with more questions than answers. After thorough examinations, her obstetrician speculated that it might have been a cord accident; however, the pathology revealed clots and an abnormally small placenta for the gestational age.
Refusing to accept vague explanations, Sarah sought out a new obstetrician who was willing to explore further. “After the initial shock and mourning, I found a new doctor who conducted extensive tests and advised me to postpone any future pregnancies until we had answers,” she recalls. This new physician identified a genetic mutation known as MTHFR, which was largely unfamiliar to Sarah and remains a somewhat contentious topic in the medical community concerning stillbirths and miscarriages.
Her new obstetrician advised against getting pregnant until comprehensive testing and a protective plan were established. Subsequently, Sarah was referred to a Maternal-Fetal Medicine (MFM) specialist who conducted additional tests. The results indicated that Sarah had an elevated risk of blood clotting during pregnancy, leading the specialist to recommend a daily prophylactic dose of Lovenox starting at eight weeks in any future pregnancies. After an early chemical pregnancy, she welcomed her rainbow baby, Emma, just two cycles later.
In addition to Lovenox, Sarah’s doctor recommended daily baby aspirin to further reduce the risk of blood clots. Through her own research, Sarah discovered that individuals with MTHFR mutations should consider taking a methylated form of folate during pregnancy, as synthetic folic acid is not effectively processed by some carriers of the mutation. Methylfolate is the active form of folate, which can be better utilized by the body, ensuring that expectant mothers provide the essential nutrients for their baby’s development.
Following a closely monitored pregnancy, Sarah’s daughter, Emma, was born healthy and thriving, just 18 months after Liam’s passing. Her heartfelt journey and the lessons learned can be heard in detail on The Birth Hour podcast, but be prepared with plenty of tissues.
Now, Sarah is committed to raising awareness about MTHFR mutations and encouraging women who have experienced unexplained pregnancy losses to find a doctor willing to investigate thoroughly. It’s important to note that not all pregnancy losses are linked to MTHFR mutations.
What is the MTHFR Gene Mutation?
So, what exactly is the MTHFR gene mutation, and how might it affect pregnancy? The MTHFR gene is present in everyone, but mutations can occur. The National Institutes of Health explain that everyone possesses two copies of the MTHFR gene, which plays a critical role in producing an enzyme that breaks down the amino acid homocysteine. Variations in the MTHFR gene can lead to different health implications.
Dr. Jason Lee, a reproductive endocrinologist, elaborates on how MTHFR mutations could potentially impact pregnancy: they may hinder folate absorption in mothers and increase the likelihood of blood clotting, both of which could affect the fetus. Additionally, Dr. Maria Garcia, a Maternal-Fetal Medicine expert, points out that some studies suggest a connection between MTHFR mutations and neural tube defects in babies. Fortunately, all pregnant women are routinely supplemented with folic acid to prevent such defects.
Dr. Lee emphasizes the link between MTHFR, folate metabolism, and dietary considerations. “Methylenetetrahydrofolate reductase (MTHFR) is crucial in the metabolism of folic acid,” he states. He highlights that variations in the MTHFR gene sequence may contribute to infertility or delayed conception in certain patients, particularly those with two copies of specific mutations who may face higher risks of blood clots due to elevated homocysteine levels.
However, Dr. Lee cautions against overreacting to an MTHFR mutation diagnosis. These mutations are relatively common, and many women who carry them do not face fertility issues. Research has shown that while some studies link MTHFR mutations with miscarriages and reproductive challenges, the majority indicate that these mutations are often benign. In fact, it is estimated that between 25% and 40% of women carry one copy of the mutation without experiencing any reproductive difficulties.
This is why many healthcare professionals, including those interviewed for this article, are skeptical about attributing fertility and pregnancy problems to MTHFR mutations. Dr. Emily Carter, an OB/GYN, references the American College of Obstetricians and Gynecologists (ACOG), which advises against routine MTHFR screening for mothers experiencing fertility issues. “ACOG does not recommend routine screening of MTHFR, as there is no clear association between MTHFR status and poor pregnancy outcomes or increased blood clot risks,” she explains.
Given the lack of support from ACOG for MTHFR testing, patients must advocate for themselves and seek healthcare providers who are informed about the latest research and willing to explore all potential causes for their reproductive health concerns. For Sarah, her MTHFR diagnosis and subsequent treatment provided the closure she needed after her loss and empowered her to take proactive steps for her future pregnancies.
“Having the mutation gave me a sense of understanding regarding my first loss,” she shares. “Taking Lovenox daily allowed me to feel I was doing everything possible for my baby’s survival, and with the support of my exceptional healthcare team, I was able to have a healthy baby and look forward to future pregnancies.”
As we await further research in the area of MTHFR gene mutations and pregnancy loss, it is crucial for anyone with concerns about their reproductive health to consult with their healthcare provider. For more information on pregnancy, consider visiting CDC’s pregnancy resource page.
In conclusion, while MTHFR mutations can play a role in pregnancy complications for some, they are far from the sole cause of pregnancy loss. Each woman’s journey is unique, and understanding the nuances of genetic mutations can help in making informed decisions about reproductive health.